Easing the arrival of advanced therapies from the pre-clinical stages to industrial production and clinical application: this is the goal of the ADVANCECAT project, an accelerator consisting of eighteen health organizations, including universities, companies, private foundations and biomedical research institutes including the Bellvitge Biomedical Research Institute (IDIBELL) through the participation of its research groups in […]
November 7th Carlos III Health Institute Bellvitge Biomedical Research Institute (IDIBELL) tackle together certain topics on the management and monitoring of this type of biomedical research projects Mª Jesús Toledo and Isabel Sastre the participants’ proposals the information and publicity channels of Structural Funds or the procurement of goods and services considerations and good practices most common difficulties disseminate good practices in the management of resources coming from Europe establish mechanisms to identify them.
Raquel Egea Dr. Jaume Reventós Medesalud 2016 innovation in health “Innovation in hospitals, experiences in Europe” “Models of research and innovation in health” the evolution of Innovation in Catalonia as a model to follow 350 participants exceptional opportunity to establish contacts with industry leaders in the Latin American region
A new study by researchers at the Bellvitge Biomedical Research Institute (IDIBELL) has found a cause of multiple resistance in cancer chemotherapy. The work, published today in the Proceedings of the National Academy of Science (PNAS) journal, the organ of expression of the United States Academy of Sciences, has been carried out by the research
Three research teams from the Bellvitge Biomedical Research Institute (IDIBELL), led by Drs Antonio Agudo, Genevieve Buckland and Sara Kozma Marató de TV3 Foundation diabetes and obesity Controlling weight and reducing obesity through dietary intervention and physical activity in breast cancer survivors Dr. Agudo Chrono-nutrition and chronotype and its relationship with obesity and type II diabetes in the study of a Spanish cohort Dr. Buckland Dr. Kozma Reducing Obesity: Anti-S6K1 Therapy
The profits of the Night will fund a project against cystic fibrosis 1st Research Charity night raise funds to promote a biomedical research project cystic fibrosis Llobregat Business Forum IDIBELL Jordi Alba Arranz-Bravo Entry price Method of payment Account number Subject firstname.lastname@example.org
Researcher Marta Díez-Ferrer is awarded for a study that improves 3D rendering of the tracheobronchial tree
PhD candidate Marta Díez-Ferrer, a member of the Pneumology research group of Bellvitge Biomedical Research Institute (IDIBELL), has been awarded 3rd prize for best original research for the oral communication “Positive airway pressure-Enhaced CT to virtual Improve bronchoscopic navigation”, which was presented at the congress of the American Association of Interventional Pulmonology and Bronchology (AABIP).
Manel Esteller, Josep Baselga and Joan Massagué receive the XXVIII Catalonia International Prize from President Puigdemont
Yesterday night, the President of the Generalitat de Catalunya (Catalan Government), Carles Puigdemont, awarded oncologists Manel Esteller, Joan Massagué and Josep Baselga the 28th Catalunya International Prize “for his revolutionary task, especially on oncology research, with what they significantly contributed to the advances of global medicine”. These awards are given every year to people who
IDIBELL and the Temporing Group Company, headquartered in Barcelona, have reached a sponsorship agreement to boost funding for research on amyotrophic lateral sclerosis (ALS). Temporing is one of the temporary employment agencies most prestigious in the Spanish market, backed by fifteen years of experience, and integrate more than one hundred forty professionals in human resources.